메뉴 건너뛰기




Volumn 328, Issue 5980, 2010, Pages 825-826

Risks of immune system treatments

(12)  Burt, Richard K a   Abinun, Mario b   Farge Bancel, Dominique c   Fassas, Athanasios d   Hiepe, Falk e   Havrdová, Eva f   Ikehara, Susumu g   Loh, Yvonne h   Champ, Alberto Marmont Du Haut i   Voltarelli, Júlio C j   Snowden, John k   Slavin, Shimon l  


Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL REGENERATION; FUNDING; GOVERNMENT; HEALTH CARE COST; HEALTH SERVICE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INFERTILITY; INFLAMMATION; LETTER; LYMPHOCYTE; METASTASIS; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; REMISSION; RESEARCH; RISK; STEM CELL TRANSPLANTATION; UNITED STATES;

EID: 77952341386     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.328.5980.825-e     Document Type: Letter
Times cited : (17)

References (10)
  • 2
    • 0026775984 scopus 로고
    • S. Than et al., J. Exp. Med. 176, 1233 (1992).
    • (1992) J. Exp. Med. , vol.176 , pp. 1233
    • Than, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.